[1]Canedo-Marroquin G, Acevedo-Acevedo O, Rey-Jurado E, et al. Modulation of host immunity by human respiratory syncytial virus virulence factors: a synergic inhibition of both innate and adaptive immunity[J]. Front Cell Infect Microbiol, 2017, 7: 367.
[2]Hall CB. Respiratory syncytial virus and parain fluenza virus. N Engl J Med. 2001, 344(25): 1917-28.
[3]Sun Z, Pan Y, Jiang S, et al. Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein. Viruses, 2013, 5(1), 211–225.
[4]张枫,谢正德. 呼吸道合胞病毒F基因及蛋白的相关研究进展[J]. 病毒学报, 2015, 31(2): 201-206.
[5]国家呼吸系统疾病临床医学研究中心, 中华医学会儿科学分会呼吸学组, 中国医师协会呼吸医师分会儿科呼吸工作委员会,等. 儿童呼吸道合胞病毒感染诊断, 治疗和预防专家共识[J]. 中华实用儿科临床杂志, 2020, 035(004):P.241-250.
[6]Johnson P R, Spriggs M K, Olmsted R A, et al.The G glycopro-tein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related pro-teins[J]. Proc Natl Acad Sci USA, 1987, 84(16): 5625-5629.
[7]Griffiths C, Drews S J, Marchant D J. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment[J]. Clinical Microbiology Reviews, 2017, 30(1): 277-319.